25-hydroxyprotopanaxadiol has been researched along with 25-methoxydammarane-3,12,20-triol in 1 studies
| Studies (25-hydroxyprotopanaxadiol) | Trials (25-hydroxyprotopanaxadiol) | Recent Studies (post-2010) (25-hydroxyprotopanaxadiol) | Studies (25-methoxydammarane-3,12,20-triol) | Trials (25-methoxydammarane-3,12,20-triol) | Recent Studies (post-2010) (25-methoxydammarane-3,12,20-triol) |
|---|---|---|---|---|---|
| 21 | 0 | 19 | 11 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rayburn, ER; Wang, H; Wang, W; Zhang, R; Zhao, Y | 1 |
1 other study(ies) available for 25-hydroxyprotopanaxadiol and 25-methoxydammarane-3,12,20-triol
| Article | Year |
|---|---|
Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Ginsenosides; Humans; Mice; Pancreatic Neoplasms; Proto-Oncogene Proteins c-mdm2; Triterpenes; Xenograft Model Antitumor Assays | 2009 |